2022
|
Question
[CLICK ON ANY CHOICE TO KNOW THE RIGHT ANSWER]
|
The Houston COVID-19 vaccine Corbevax got DCGI approval for use in India. Who is the incumbent Drugs Controller General of India?
|
|
K. K. Venugopal
|
|
|
Amit Kumar
|
|
|
Milon K. Banerji
|
|
|
V. G. Somani
|
Explanation:
Detailed explanation-1: -Pharmaceuticals firm Biological E Ltd’s COVID-19 vaccine, Corbevax, became the first vaccine to be approved by the Drugs Controller General of India (DCGI) as a booster dose for the 18-plus age group. “Corbevax gets DCGI nod as a heterologous COVID-19 booster dose, announces Biological E.
Detailed explanation-2: -COVAXIN®, India’s indigenous COVID-19 vaccine by Bharat Biotech is developed in collaboration with the Indian Council of Medical Research (ICMR) - National Institute of Virology (NIV).
Detailed explanation-3: -Covaxin. This vaccine is approved.
There is 1 question to complete.